Kantum Diagnostics, Inc. reported raising $805,000 in an initial SEC Form D filing, from an offering of $2 Million
PRIVATEOct 12, 2018
Amount Raised
$805,000
$805,000 sold, per SEC Form D (first sale Oct 12, 2018)
Round Type
Seed
ConcordInformation TechnologyBiotechnologyWho to call at Kantum Pharma, Inc., and when
A new round usually means Kantum Pharma, Inc. is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Kantum Pharma, Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Kantum Pharma, Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Kantum Pharma, Inc.. With Fundz connected, it knows.
Watch Fundz in
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Kantum Pharma, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Kantum Pharma, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.